From:  Cognitive and neuropsychiatric outcomes in economically active young patients with epilepsy: a case-control study from a secondary medical center in Mexico

 Cognitive performance

Cognitive screening toolsPatients
n = 25
Controls
n = 25
P-value
3a. MoCA and ACE-II total scores
MoCAMean20.7624.280.044
Standard deviation3.4914.505
Standard error mean0.6980.901
ACE-IIIMean69.0881.320.206
Standard deviation11.9799.4919
Standard error mean2.3961.882
3b. MoCA and ACE-III screening results for cognitive impairment
MoCANo cognitive impairment4 (16%)12 (48%)0.015
Cognitive impairment21 (84%)13 (52%)
ACE-IIINo cognitive impairment4 (16%)16 (64%)< 0.001
Cognitive impairment21 (84%)9 (36%)
3c. Verbal and semantic fluency performance
Verbal fluency< 11 per minute16 (64%)7 (28%)0.011
≥ 11 per minute9 (36%)18 (72%)
Semantic fluency< 17 per minute19 (76%)11 (44%)0.027
≥ 17 per minute6 (24%)14 (56%)

3a. MoCA and ACE-III total scores: Displays the total scores for Montreal Cognitive Assessment (MoCA) and Addenbrooke’s Cognitive Examination (ACE-III). Statistical analysis was performed using the Student’s T-test. 3b. MoCA and ACE-III screening results for cognitive impairment: The dichotomous analysis of cognitive impairment using MoCA and ACE-III is presented as a 2 × 2 Chi-square table. 3c. Verbal and semantic fluency performance: This section displays verbal and semantic fluency results, analyzed as a 2 × 2 Chi-square table. P-values are reported to indicate statistical significance